Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AGRX | C | Agile Therapeutics, Inc. | 0.00 | |
IMUX | C | Immunic, Inc. | 1.26 | |
GMED | B | Globus Medical, Inc. | 0.89 | |
LDOS | A | Leidos Holdings, Inc. | 0.75 | |
MORF | A | Morphic Holding, Inc. | 0.00 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EIRL | D | iShares MSCI Ireland Capped ETF | 20.68 | |
PCIG | C | Polen Capital International Growth ETF | 11.4 | |
HELX | D | Franklin Genomic Advancements ETF | 8.88 | |
BBH | D | Market Vectors Biotech ETF | 6.42 | |
JSMD | A | Janus Small/Mid Cap Growth Alpha ETF | 4.51 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biology
Biotechnology
Biopharmaceutical
Life Sciences
Medicine
Clinical Trial
Contract Research Organization
Contract Research Organizations
Diabetes
Schizophrenia
Achondroplasia
Acute Intermittent Porphyria
Adeno Associated Virus
Alcohol
Alipogene Tiparvovec
Amyloid
Amyloidosis
Anemia
Antibody
Antipsychotic
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles